Clinical Trial Update: Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety, tolerability, and pharmacokinetics of BFKB8488A in otherwise healthy overweight/obese individuals with likely insulin resistan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Drugs mentioned

• BFKB8488A

Snippet

Sponsor: Genentech, Inc. | Conditions: Insulin Resistance | Phase 1 | Status: COMPLETED